FORT LAUDERDALE, Fla. — Myopic traction maculopathy, or MTM, is an evolving disease that requires different management at different stages.
In the advanced stages, buckling leads to high rates of anatomic and functional success, one speaker said at Retina World Congress.
After 15 years of experience in hundreds of cases, Barbara Parolini, MD, published the Myopic Traction Maculopathy Staging System, which recently obtained international validation by the Retina World Congress Global Research Group.
“It summarizes everything you need to know on MTM — the nomenclature, the